Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
clinical trials
deals
fda
3
×
life sciences
national blog main
alnylam pharmaceuticals
boston top stories
national top stories
new york blog main
new york top stories
novartis
sanofi
abbvie
akouos
alexion pharmaceuticals
alirocumab
allergan
amag pharmaceuticals
amgen
amunix
amyotrophic lateral sclerosis (als)
anirvan ghosh
astrazeneca
autoimmune disorders
biogen
bluerock therapeutics
boston
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
cerovene
complement system
covid-19
crispr
deerfield management
detroit blog main
detroit top stories
What
deal
3
×
medicines
drug
acquire
acquisitions
agreed
alternative
announced
autoimmune
billion
bio
brings
candidate
cash
ceo
cholesterol
collabs
company
compound
covid
daniel
disease
expensive
fda
gilead
gilead’s
help
introduce
ipo
lead
medco
month
new
novartis
o’day
pharma
pharmaceuticals
plans
poised
potential
Language
unset
3
×
Current search:
deal
×
unset
×
fda
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma
